Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Xian Deng
UBS
Xian Deng
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+12.8%
Average Return
1 of 1 calls profitable · +11.3% vs benchmark
📈 Across the calls we could measure, roughly 100% of Xian Deng's ratings turned a profit when each position was held for 1 year — averaging +12.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 15 Hold 0 Sell
Xian's Stock Coverage 13 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
GB:0NZT
UCB SA
Jun 09, 2026 BUY Buy
-15.2% avg upside
19 analysts
$330.00
31.93% Upside
·
FR:IPN
Ipsen
May 19, 2026 HOLD Buy
-21.9% avg upside
17 analysts
$170.00
8.72% Upside
·
ZLDPF
Zealand Pharma
May 08, 2026 BUY Buy
+91.6% avg upside
11 analysts
$113.42
153.49% Upside
·
GB:0QW0
arGEN X
May 08, 2026 HOLD Strong Buy
-24.9% avg upside
24 analysts
·
ARGX
Argenx Se
May 08, 2026 HOLD Strong Buy
-15.9% avg upside
46 analysts
$850.00
3.20% Downside
+12.8%
NL:LKFT
Galapagos
Apr 01, 2026 HOLD Sell
+112.9% avg upside
16 analysts
$30.00
22.09% Upside
·
GB:0MGB
Genmab A/S
Mar 26, 2026 BUY Buy
+31.5% avg upside
22 analysts
$2600.00
57.13% Upside
·
CH:BIOV
BioVersys AG
Dec 11, 2025 BUY Strong Buy
+64.0% avg upside
2 analysts
$48.00
79.88% Upside
·
CH:LONN
Lonza Group Ltd
Feb 06, 2023 BUY Strong Buy
+26.0% avg upside
19 analysts
$605.00
21.27% Upside
·
DE:MDG1
Medigene
Aug 04, 2022 BUY Strong Buy
+37283.1% avg upside
2 analysts
$8.00
37283.13% Upside
·
GB:0FWY
SalMar ASA
May 26, 2020 HOLD Sell
-3.0% avg upside
4 analysts
$450.00
16.88% Downside
·
GB:0OAW
Mowi ASA
Feb 17, 2020 BUY Strong Buy
+21.1% avg upside
5 analysts
$255.00
32.28% Upside
·
NL:CRBN
Corbion NV
Nov 01, 2019 BUY Strong Buy
+69.0% avg upside
5 analysts
$31.00
52.77% Upside
·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Xian Deng — Frequently Asked Questions
How accurate are Xian Deng's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Xian's ratings were profitable over a one-year hold, with an average return of +12.8% per rating, or +11.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Xian ranked on 13Foresight?
Xian Deng is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Xian cover?
Xian most recently has ratings on GB:0NZT, FR:IPN, ZLDPF, GB:0QW0, ARGX, NL:LKFT, GB:0MGB, CH:BIOV, CH:LONN, DE:MDG1, GB:0FWY, GB:0OAW and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.